UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000054497
Receipt number R000062255
Scientific Title Multicenter study to evaluate the efficacy and safety of combination therapy with LHRH antagonist, androgen-receptor signaling inhibitor, and denosumab followed by local radiation therapy in patients with multiple metastatic prostate cancer
Date of disclosure of the study information 2024/05/28
Last modified on 2025/11/28 13:43:15

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Multi-institutional study to evaluate the efficacy and safety of hormone therapy with radiation therapy for prostate cancer with multiple bone metastases

Acronym

Efficacy of multidisciplinary treatment including radiotherapy for prostate cancer with multiple bone metastases

Scientific Title

Multicenter study to evaluate the efficacy and safety of combination therapy with LHRH antagonist, androgen-receptor signaling inhibitor, and denosumab followed by local radiation therapy in patients with multiple metastatic prostate cancer

Scientific Title:Acronym

Efficacy of multidisciplinary treatment including radiotherapy for prostate cancer with multiple bone metastases

Region

Japan


Condition

Condition

Patients with prostate cancer who had multiple bone metastases

Classification by specialty

Urology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The aim of this study is to evaluate the utility and safety of the combination enzalutamide and ADT as a first-line treatment followed by RT for prostate in patients with mCSPC who had high-volume bone metastasis.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Efficacy of this combination treatments on oncological outcomes

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine Maneuver

Interventions/Control_1

Degarelix, Denosumab, Enzarutamide, Radiation

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

90 years-old >=

Gender

Male

Key inclusion criteria

histologically confirmed PCa with high burden synchronous metastatic disease (4 and more bone metastases), Eastern Cooperative Oncology Group performance status of 0-1, adequate bone marrow function (absolute neutrophil count 1500/m3 and more and platelet count 100000/m3 and more), adequate renal function (creatinine 2.0 mg/dL and less and/or creatinine clearance 40 mL/min and more), and adequate hepatic function (total bilirubin 1.5 mg/dL and less).

Key exclusion criteria

Patients who had previously undergone RT for the prostate or pelvis, or had received chemotherapy or hormonal therapy for PCa, were excluded. The patients who received finasteride or dutasteride before the surgery were also excluded from the present study.

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Takuya
Middle name
Last name Koie

Organization

Gifu University Graduate School of Medicine

Division name

Urology

Zip code

5011194

Address

1-1 Yanagido, Gifu, Japan

TEL

0582306000

Email

koie.takuya.h2@f.gifu-u.ac.jp


Public contact

Name of contact person

1st name Makoto
Middle name
Last name Kawase

Organization

Gifu University Graduate School of Medicine

Division name

Urology

Zip code

5011194

Address

1-1 Yanagido, Gifu, Japan

TEL

0582306000

Homepage URL


Email

kawase.makoto.g5@f.gifu-u.ac.jp


Sponsor or person

Institute

Department of Urology, Gifu University Graduate School of Medicine
Takuya Koie

Institute

Department

Personal name



Funding Source

Organization

Astelas pharmacy

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Gifu University Graduate School of Medicine

Address

1-1 Yanagido, Gifu, Japan

Tel

0582306000

Email

koie.takuya.h2@f.gifu-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 05 Month 28 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications

https://onlinelibrary.wiley.com/doi/10.1002/cnr2.70355

Number of participants that the trial has enrolled

35

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2021 Year 06 Month 14 Day

Date of IRB

2021 Year 08 Month 04 Day

Anticipated trial start date

2021 Year 12 Month 01 Day

Last follow-up date

2027 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2024 Year 05 Month 28 Day

Last modified on

2025 Year 11 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000062255

Research Plan
Registered date File name
2024/11/27 documents.pdf
Research case data specifications
Registered date File name
2024/11/28 polymets data 元.xlsx
Research case data
Registered date File name
2024/11/28 polymets data.xlsx

Single case data URL

Value
https://center6.umin.ac.jp/ice/62255